Synthetic Malarial Drug Ingredient Could Cut Cost Of Treatment

NPR | April 10, 2013 3:17 p.m.

Contributed By:

Jason Beaubien

Scientists have come up with a new way to produce the most common anti-malaria medicine currently on the market and a French pharmaceutical company is opening a new plant this week to manufacture it. The synthetic version of artemisinin is expected to stabilize the malaria medicine market and reduce the overall cost of malaria treatment.


blog comments powered by Disqus
Follow us
Thanks to our Sponsors:
become a sponsor
Thanks to our Sponsors
become a sponsor